Neurotype Overview
- Year Founded
-
2019

- Status
-
Private
- Employees
-
4

- Latest Deal Type
-
Grant
- Latest Deal Amount
-
$329K
- Investors
-
4
Neurotype General Information
Description
Developer of brain sensor and software platform intended to help people overcome environmental triggers for addictive behaviors like drug use and overeating. The company's device objectively detects drug cravings in patients undergoing treatment for opioid use disorder and provides strategies to combat cravings, enabling improved mental and behavioral healthcare.
Contact Information
Website
www.neurotype.ioCorporate Office
- 4610 East Lake Street
- Suite 306
- Minneapolis, MN 55406-2364
- United States
Corporate Office
- 4610 East Lake Street
- Suite 306
- Minneapolis, MN 55406-2364
- United States
Neurotype Timeline
Neurotype Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
11. Grant | 01-Oct-2023 | $329K | Completed | Product Development | ||
10. Grant | 01-Jul-2023 | Completed | Product Development | |||
9. Grant | 19-Oct-2022 | Completed | Product Development | |||
8. Grant | 10-Oct-2022 | Completed | Product Development | |||
7. Grant | 28-Feb-2022 | Completed | Product Development | |||
6. Accelerator/Incubator | 15-Apr-2021 | Completed | Startup | |||
5. Grant | 15-Sep-2020 | Completed | Product Development | |||
4. Grant | 15-Jul-2020 | Completed | Startup | |||
3. Accelerator/Incubator | 01-Jan-2020 | $405K | $405K | Completed | Startup | |
2. Grant | 15-Dec-2019 | $10K | Completed | Startup |
Neurotype Patents
Neurotype Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-12343157-B2 | Assessing motivated attention with cue reactivity | Active | 14-Apr-2020 | ||
US-20210315508-A1 | Assessing motivated attention with cue reactivity | Active | 14-Apr-2020 |
Neurotype Signals
Neurotype Investors (4)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
---|---|---|---|---|
Minnesota Department of Employment and Economic Development | Government | |||
National Institutes of Health | Government | |||
National Institute on Drug Abuse (NIDA) | Government | |||
Yale University | University |
Neurotype FAQs
-
When was Neurotype founded?
Neurotype was founded in 2019.
-
Where is Neurotype headquartered?
Neurotype is headquartered in Minneapolis, MN.
-
What is the size of Neurotype?
Neurotype has 4 total employees.
-
What industry is Neurotype in?
Neurotype’s primary industry is Monitoring Equipment.
-
Is Neurotype a private or public company?
Neurotype is a Private company.
-
What is Neurotype’s current revenue?
The current revenue for Neurotype is
. -
How much funding has Neurotype raised over time?
Neurotype has raised $460K.
-
Who are Neurotype’s investors?
Minnesota Department of Employment and Economic Development, National Institutes of Health, National Institute on Drug Abuse (NIDA), and Yale University have invested in Neurotype.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »